KORU Medical Systems (KRMD) Research & Development (2010 - 2026)

KORU Medical Systems (KRMD) has reported Research & Development for 12 consecutive years, with $1.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Research & Development fell 10.51% year-over-year to $1.1 million in Q2 2026; TTM through Jun 2026 was $4.5 million, a 9.96% decrease from a year earlier, with the FY2025 full-year figure at $4.4 million, down 16.56% from the prior year.
• Research & Development was $1.1 million for Q2 2026 at KORU Medical Systems, down from $1.3 million in the prior quarter.
• Over five years, Research & Development peaked at $1.6 million in Q4 2022 and troughed at $862148.0 in Q3 2022.
• A 5-year average of $1.3 million and a median of $1.2 million in 2023 frame the typical range for Research & Development.
• Across the five-year window, Research & Development surged 240.92% in 2022 and sank 39.17% in 2025, its largest moves.
• Over 5 years, Research & Development stood at $1.6 million in 2022, then retreated by 21.59% to $1.3 million in 2023, then slipped by 13.46% to $1.1 million in 2024, then gained by 2.74% to $1.1 million in 2025, then decreased by 6.6% to $1.1 million in 2026.
• The last three Research & Development figures came in at $1.1 million (Q2 2026), $1.3 million (Q1 2026), and $1.1 million (Q4 2025), per Business Quant data.